רקויפ מודוטאב 4 מ"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

ROPINIROLE AS HYDROCHLORIDE 4 MG

MAH:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC_code:

N04BC04

pharmaceutical_form:

FILM COATED TABLETS - PROLONGED RELEASE

administration_route:

PER OS

manufactured_by:

SMITHKLINE BEECHAM PLC, UK

therapeutic_group:

ROPINIROLE

therapeutic_indication:

Ropinirole is indicated for the treatment of Parkinson's disease. Ropinirole is effective as early therapy in patients requiring dopaminergic therapy. As adjunctive treatment to L-dopa, ropinirole enhances the efficacy of L-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic L-dopa therapy and permits reduction in daily L-dopa dose.

authorization_date:

2009-09-01